Search research articles
Contact Us
Filters
Showing results (141-150 of 304) with videos related to
Page
of 31
Sort By:
Multiple Sclerosis and Related Disorders
|
March 20, 2026
Safety and patient experiences with the natalizumab biosimilar in multiple sclerosis treatment
Liza M Y Gelissen, Eva M M Strijbis, Bob W van Oosten, et al.
Arthritis Research & Therapy
|
February 22, 2019
Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Scientific Reports
|
July 12, 2019
Human DC-SIGN and CD23 do not interact with human IgG
A Robin Temming, Gillian Dekkers, Fleur S van de Bovenkamp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 18, 2024
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, et al.
The AAPS Journal
|
September 8, 2016
Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®
Joseph C Marini, Jocelyn Sendecki, Freddy Cornillie, et al.
Scientific Reports
|
July 25, 2020
Author Correction: Human DC-SIGN and CD23 do not interact with human IgG
A Robin Temming, Gillian Dekkers, Fleur S van de Bovenkamp, et al.
European Journal of Immunology
|
October 7, 2025
Anti-SARS-CoV-2 Spike IgA2 Induces Inflammation by Human Macrophages
Lynn Mes, Jennifer Veth, Julie Van Coillie, et al.
Molecular Immunology
|
December 22, 2017
Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice
Gillian Dekkers, Arthur E H Bentlage, Rosina Plomp, et al.
Frontiers in Neurology
|
October 25, 2021
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
Jose M Serra López-Matencio, Yaiza Pérez García, Virginia Meca-Lallana, et al.
Blood
|
October 30, 2014
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
Sietse Q Nagelkerke, Gillian Dekkers, Iwan Kustiawan, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 304) with videos related to
Sort By:
Page
of 31
Multiple Sclerosis and Related Disorders
|
March 20, 2026
Safety and patient experiences with the natalizumab biosimilar in multiple sclerosis treatment
Liza M Y Gelissen, Eva M M Strijbis, Bob W van Oosten, et al.
Arthritis Research & Therapy
|
February 22, 2019
Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Scientific Reports
|
July 12, 2019
Human DC-SIGN and CD23 do not interact with human IgG
A Robin Temming, Gillian Dekkers, Fleur S van de Bovenkamp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 18, 2024
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, et al.
The AAPS Journal
|
September 8, 2016
Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®
Joseph C Marini, Jocelyn Sendecki, Freddy Cornillie, et al.
Scientific Reports
|
July 25, 2020
Author Correction: Human DC-SIGN and CD23 do not interact with human IgG
A Robin Temming, Gillian Dekkers, Fleur S van de Bovenkamp, et al.
European Journal of Immunology
|
October 7, 2025
Anti-SARS-CoV-2 Spike IgA2 Induces Inflammation by Human Macrophages
Lynn Mes, Jennifer Veth, Julie Van Coillie, et al.
Molecular Immunology
|
December 22, 2017
Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice
Gillian Dekkers, Arthur E H Bentlage, Rosina Plomp, et al.
Frontiers in Neurology
|
October 25, 2021
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
Jose M Serra López-Matencio, Yaiza Pérez García, Virginia Meca-Lallana, et al.
Blood
|
October 30, 2014
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
Sietse Q Nagelkerke, Gillian Dekkers, Iwan Kustiawan, et al.
Page
of 31